Search results

Clinical trial

Republic of Taiwan: Non-small cell lung cancer treatment options

  • As soon as possible
  • Republic of Taiwan
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

Korea: Non-small cell lung cancer treatment options

  • As soon as possible
  • Korea
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

United States: Non-small cell lung cancer treatment options

  • As soon as possible
  • United States
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

Australia: Non-small cell lung cancer treatment options

  • As soon as possible
  • Australia
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

US: Diabetic Macular Edema (DME)

  • As soon as possible
  • US
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

US: Influenza, RSV, and SARS-CoV-2 vaccines

  • As soon as possible
  • US
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

UK: Influenza, RSV, and SARS-CoV-2 vaccines

  • As soon as possible
  • UK
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical trial

Australia: Influenza, RSV, and SARS-CoV-2 vaccines

  • As soon as possible
  • Australia
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical Trial

US: Most effective dose of vaccine for preventing Cytomegalovirus (CMV)

  • As soon as possible, until December 2023
  • United States
  • To be disclosed by the client
EN SAVOIR PLUS
Clinical Trial

Canada: Most effective dose of vaccine for preventing Cytomegalovirus (CMV)

  • As soon as possible, until December 2023
  • Canada
  • To be disclosed by the client
EN SAVOIR PLUS